Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Vannata

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Haematologica|June 10, 2017
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratificationLuca Laurenti, Idanna Innocenti, Francesco Autore, et al.
Cancers|January 15, 2021
Enhanced Expression of <i>miR-181b</i> in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell ResponseMirco Di Marco, Serena Veschi, Paola Lanuti, et al.
Leukemia Research|August 27, 2015
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departmentsLuca Laurenti, Idanna Innocenti, Francesco Autore, et al.
Hematological Oncology|June 22, 2025
Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)Annarita Conconi, Andrea Janikova, Barbara Vannata, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Haematologica|June 10, 2017
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratificationLuca Laurenti, Idanna Innocenti, Francesco Autore, et al.
Cancers|January 15, 2021
Enhanced Expression of <i>miR-181b</i> in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell ResponseMirco Di Marco, Serena Veschi, Paola Lanuti, et al.
Leukemia Research|August 27, 2015
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departmentsLuca Laurenti, Idanna Innocenti, Francesco Autore, et al.
Hematological Oncology|June 22, 2025
Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)Annarita Conconi, Andrea Janikova, Barbara Vannata, et al.
Pageof 3